相似文献
1
microRNA-Based Cancer Diagnosis and Therapy.
Int J Mol Sci. 2023 Dec 22;25(1):230. doi: 10.3390/ijms25010230.
2
MicroRNA trafficking and human cancer.
Cancer Biol Ther. 2006 Jun;5(6):573-8. doi: 10.4161/cbt.5.6.2872. Epub 2006 Jun 2.
3
The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
Semin Cancer Biol. 2008 Apr;18(2):89-102. doi: 10.1016/j.semcancer.2008.01.004. Epub 2008 Jan 15.
4
MicroRNA-224: as a potential target for miR-based therapy of cancer.
Tumour Biol. 2015 Sep;36(9):6645-52. doi: 10.1007/s13277-015-3883-3. Epub 2015 Aug 8.
5
MicroRNA profiling in cancer.
Clin Sci (Lond). 2011 Aug;121(4):141-58. doi: 10.1042/CS20110005.
6
Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
J Exp Clin Cancer Res. 2021 Dec 4;40(1):383. doi: 10.1186/s13046-021-02193-1.
7
The role of extracellular vesicle microRNAs in cancer biology.
Clin Chem Lab Med. 2017 May 1;55(5):648-656. doi: 10.1515/cclm-2016-0708.
8
MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment.
Int J Cancer. 2008 Mar 1;122(5):963-8. doi: 10.1002/ijc.23325.
9
Shielding the messenger (RNA): microRNA-based anticancer therapies.
Pharmacol Ther. 2011 Jul;131(1):18-32. doi: 10.1016/j.pharmthera.2011.04.006. Epub 2011 Apr 14.
10
microRNA Therapeutics in Cancer - An Emerging Concept.
EBioMedicine. 2016 Oct;12:34-42. doi: 10.1016/j.ebiom.2016.09.017. Epub 2016 Sep 20.
引用本文的文献
1
miR-574-3p Regulates Smad/Snail Signaling to Promote Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Cells.
Biochem Genet. 2025 Jul 9. doi: 10.1007/s10528-025-11182-4.
2
The Role and Function of Non-Coding RNAs in Cholangiocarcinoma Invasiveness.
Biomedicines. 2025 Jun 3;13(6):1369. doi: 10.3390/biomedicines13061369.
3
Identification of novel diagnostic and prognostic microRNAs in sarcoma on TCGA dataset: bioinformatics and machine learning approach.
Sci Rep. 2025 Mar 4;15(1):7521. doi: 10.1038/s41598-025-91007-x.
4
Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.
Noncoding RNA. 2025 Jan 12;11(1):3. doi: 10.3390/ncrna11010003.
5
miR-424-5p Promotes Proliferation, Migration and Invasion of Colorectal Cancer Cells via the Targeting TXNIP/Hippo Axi.
Int J Gen Med. 2025 Jan 16;18:261-271. doi: 10.2147/IJGM.S497401. eCollection 2025.
6
MicroRNA-582-5p inhibits the progression of gastric cancer cells and their resistance to oxaliplatin by suppressing ATG7 expression.
Front Oncol. 2024 Oct 11;14:1481266. doi: 10.3389/fonc.2024.1481266. eCollection 2024.
7
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma.
Open Life Sci. 2024 Aug 6;19(1):20220936. doi: 10.1515/biol-2022-0936. eCollection 2024.
本文引用的文献
1
A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer.
Pathol Res Pract. 2023 Nov;251:154848. doi: 10.1016/j.prp.2023.154848. Epub 2023 Oct 5.
2
MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations.
Adv Pharm Bull. 2023 Jul;13(3):435-445. doi: 10.34172/apb.2023.047. Epub 2022 Jul 2.
3
Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments.
J Biomed Sci. 2023 Aug 21;30(1):69. doi: 10.1186/s12929-023-00964-w.
4
Machine learning algorithms reveal potential miRNAs biomarkers in gastric cancer.
Sci Rep. 2023 Apr 15;13(1):6147. doi: 10.1038/s41598-023-32332-x.
5
Circularized RNA as novel therapeutics in cancer.
Int J Biochem Cell Biol. 2023 Mar;156:106364. doi: 10.1016/j.biocel.2023.106364. Epub 2023 Jan 10.
6
Targeting non-coding RNAs to overcome cancer therapy resistance.
Signal Transduct Target Ther. 2022 Apr 13;7(1):121. doi: 10.1038/s41392-022-00975-3.
7
Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy.
J Hematol Oncol. 2022 Feb 5;15(1):14. doi: 10.1186/s13045-022-01230-6.
8
Circular RNA circCCDC85A inhibits breast cancer progression via acting as a miR-550a-5p sponge to enhance MOB1A expression.
Breast Cancer Res. 2022 Jan 4;24(1):1. doi: 10.1186/s13058-021-01497-6.
9
Machine Learning-Based Ensemble Recursive Feature Selection of Circulating miRNAs for Cancer Tumor Classification.
Cancers (Basel). 2020 Jul 3;12(7):1785. doi: 10.3390/cancers12071785.
10
miR-155 as a novel clinical target for hematological malignancies.
Carcinogenesis. 2020 Mar 13;41(1):2-7. doi: 10.1093/carcin/bgz183.
Zotero 插件